Cure My Disease
Don't miss your cure!
Clinical trials sponsored by Chengdu Suncadia Medicine Co., Ltd., explained in plain language.
This study looks at the long-term safety of a drug called HRS-5965 in people with paroxysmal nocturnal hemoglobinuria (PNH), a rare blood disorder. Participants who previously took HRS-5965 and benefited from it will continue taking it. Researchers will track side effects and how…
Phase: PHASE2 • Sponsor: Chengdu Suncadia Medicine Co., Ltd. • Aim: Disease control
Last updated May 11, 2026 20:48 UTC